Filing Details
- Accession Number:
- 0001385508-21-000131
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-15 16:01:35
- Reporting Period:
- 2021-09-13
- Accepted Time:
- 2021-09-15 16:01:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385508 | Opiant Pharmaceuticals Inc. | OPNT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363558 | A Craig Collard | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd., Suite 280 Santa Monica CA 90401 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-13 | 2,500 | $18.13 | 16,077 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 506 | $17.96 | 16,583 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 700 | $18.07 | 17,283 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $18.05 to $18.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $17.94 to $17.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $18.02 to $18.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
